Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RVMD
RVMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RVMD News
EMA Accelerates Review of Daraxonrasib for Pancreatic Cancer
21h ago
Newsfilter
EU Accelerates Review of Daraxonrasib for Pancreatic Cancer
21h ago
seekingalpha
Biotech Stocks Outperform S&P 500 in H1 2026
1d ago
Fool
Biotech Companies Reach Critical Turning Point
1d ago
NASDAQ.COM
Revolution Medicines Stock Soars 140% Amid Promising Trials
2d ago
Fool
Revolution Medicines Advances Cancer Treatment Approaches
2d ago
NASDAQ.COM
Revolution Medicines Stock Soars 140%: Is It Still a Buy?
2d ago
Yahoo Finance
Jim Cramer Endorses Medline as Best IPO of the Year
6d ago
CNBC
Revolution Medicines' Cancer Drug Development Outlook
6d ago
NASDAQ.COM
Revolution Medicines Achieves $40 Billion Market Cap
6d ago
Fool
Surge in Options Trading Volume for IBM and Groupon
Jun 25 2026
NASDAQ.COM
Revolution Medicines to Present New Data at ESMO Congress
Jun 24 2026
Newsfilter
Revolution Medicines' Pancreatic Cancer Therapy Nears Approval
Jun 11 2026
NASDAQ.COM
Revolution Medicines Achieves Breakthrough with New Drug for Pancreatic Cancer
Jun 11 2026
Fool
Tango Therapeutics Raises Drug Sales Estimate to $2.6 Billion
Jun 08 2026
stocktwits
Tango Therapeutics Shares Surge 32% on Promising Trial Data for Vopimetostat
Jun 08 2026
seekingalpha
Show More News
